BVS - CIK 0001665988
The table below shows Bioventus Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $35.85M | $42.16M | $32.91M | $22.80M | $43.07M | $31.99M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $120.53M | $130.40M | $132.37M | $118.08M | $121.92M | $137.31M |
| Inventory | $83.19M | $96.27M | $96.47M | $94.05M | $90.03M | $87.61M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $249.81M |
| $280.90M |
| $275.20M |
| $249.37M |
| $298.69M |
| $308.88M |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | $7.46M | $7.46M | $7.46M | $7.46M | $7.46M | $7.46M |
| Total assets | $650.54M | $701.59M | $706.79M | $691.41M | $769.49M | $792.17M |
| Accounts payable | $24.05M | $26.65M | $24.25M | $19.20M | $16.85M | $24.44M |
| Total current liabilities | $148.09M | $161.75M | $185.68M | $174.75M | $211.49M | $231.46M |
| Long-term debt | $253.33M | $311.33M | $297.88M | $308.59M | $345.02M | $344.72M |
| Total liabilities | $416.27M | $494.34M | $505.49M | $505.94M | $582.66M | $603.11M |
| Retained earnings | -$331.82M | -$349.68M | -$352.84M | -$360.30M | -$354.92M | -$350.10M |
| Total equity | $188.90M | $166.10M | $161.24M | $148.14M | $148.74M | $150.94M |